Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Seroprevalence of Hepatitis B Virus Infection and Hepatitis B Surface Antibody Status Among Laboratory Health Care Workers in Isfahan, Iran Publisher



Shoaei P1 ; Najafi S2 ; Lotfi N3 ; Vakili B1 ; Ataei B3 ; Yaran M2 ; Shafiei R3
Authors
Show Affiliations
Authors Affiliations
  1. 1. Nosocomial Infection Research Center, Isfahan University of Medical Sciences, Isfahan, Iran
  2. 2. Acquired Immunodeficiency Research Center, Isfahan University of Medical Sciences, Isfahan, Iran
  3. 3. Infectious Diseases Research Center, Isfahan University of Medical Sciences, Isfahan, Iran

Source: Asian Journal of Transfusion Science Published:2015


Abstract

Background: Laboratory health care workers (HCWs) may become infected through their occupation with blood-borne pathogens. The aims of this study were determining the seroprevalence of hepatitis B virus (HBV) and the protection offered by HBV vaccine in medical laboratory HCWs. Materials and Methods: A descriptive cross-sectional study was carried out on 203 employers of clinical laboratories. Participant data were obtained through a questionnaire, and the level of antigens and antibodies were measured by enzyme-linked immunosorbent assay (ELISA). Results: All of the subjects were negative for HBV infection. Forty-seven (23.2%) were not immune, 126 (62.0%) were relatively immune, and 30 (14.8%) were highly immune. Conclusion: Hepatitis B infection is infrequent in laboratory HCWs in Isfahan. © 2015 Asian Journal of Transfusion Science.
Related Docs
View other Related Docs
1. Seroprevalence of Hepatitis C Infection Among Laboratory Health Care Workers in Isfahan, Iran, International Journal of Preventive Medicine (2012)
2. Occult Hepatitis B Virus Infection Among Human Immunodeficiency Virus-Infected Patients With Isolated Hepatitis B Core Antibody in Isfahan, Iran, Journal of Research in Medical Sciences (2014)
3. Seroprevalence of Hepatitis B Infection and Associated Risk Factors Among Drug Users in Drop-In Centers of Isfahan, Iran, International Journal of Preventive Medicine (2018)
4. The Assessment of Hepatitis B Seroprevalence in Persons With Intravenous Drug Use History in the Isfahan Province: Community-Based Study, Journal of Research in Medical Sciences (2014)
5. Hepatitis B Markers in Isfahan, Central Iran: A Population-Based Study, Hepatitis Monthly (2009)
6. Antibody Titer in Iranian Children 6 Years After Hepatitis B Vaccine Administration, Vaccine (2007)
7. Hepatitis B Virus Genotype, Hbsag Mutations and Co-Infection With Hcv in Occult Hbv Infection, Clinics and Research in Hepatology and Gastroenterology (2011)
8. Prevalence of Hepatitis B Virus Infection in Isfahan Province, International Journal of Preventive Medicine (2014)
Experts (# of related papers)
View all Related Experts
Behrooz Ataei (41)
Nazila Kassaian (25)
Other Related Docs
9. Effect of Tetanus-Diphtheria Vaccine on Immune Response to Hepatitis B Vaccine in Low-Responder Individuals, International Journal of Preventive Medicine (2016)
10. Hepatitis D Virus Infection in Isfahan, Central Iran: Prevalence and Risk Factors Among Chronic Hbv Infection Cases, Hepatitis Monthly (2011)
11. Comparing the Effectiveness of a Short-Term Double-Dose Hepatitis B Vaccination Schedule With the Standard 3-Dose Schedule: A Randomized Clinical Trial, Tehran University Medical Journal (2011)
12. Occult Hepatitis B Virus Infection Among Blood Donors With Antibodies to Hepatitis B Core Antigen, Acta Medica Iranica (2008)
13. Effect of Tetanus-Diphtheria (Td) Vaccine on Immune Response to Hepatitis B Vaccine in Healthy Individuals With Insufficient Immune Response, Journal of Research in Medical Sciences (2015)
14. Effectiveness of Hepatitis B Vaccination in Children of Chronic Hepatitis B Mothers, Saudi Medical Journal (2004)
15. Efficacy of Double Dose Recombinant Hepatitis B Vaccination in Chronic Hepatitis C Patients, Compared to Standard Dose Vaccination, International Journal of Preventive Medicine (2014)
16. Hepatitis G Virus Exposure in Dialysis Patients and Blood Donors in Isfahan-Iran, International Journal of Preventive Medicine (2014)
17. The Prevalence of Hepatitis B, Hepatitis C and Associated Risk Factors in Intravenous Drug Addicts (Ivda) With Hiv in Isfahan, Journal of Isfahan Medical School (2008)
18. Seroprevalence of Hepatitis E in Patients With Chronic Liver Disease From East Azerbaijan, Iran, Hepatitis Monthly (2007)
19. Anti-Hepatitis E Antibody in Hemodialysis Patients in Isfahan, Iran: Prevalence and Risk Factors, Hepatitis Monthly (2015)
20. Hepatitis a Seropositivity Among First-Year Students of the Medical University in Isfahan, Iran, International Journal of Preventive Medicine (2014)
21. How Much Does Vaccination Reduce the Rate of Hbv Infection in Iranian Population? a Bayesian Adjustment Analysis, Gastroenterology and Hepatology from Bed to Bench (2019)
22. Hepatitis a Seropositivity Among Newly Admitted Medical Students of Isfahan, Kermanshah, and Hamedan: A Seroprevalence Study, Journal of Research in Medical Sciences (2014)
23. Seroprevalence of Hepatitis B in Nahavand, Islamic Republic of Iran, Eastern Mediterranean Health Journal (2006)
24. Comparison of Hbs-Antibody Serum Levels Between Patients With Type 2 Diabetes Mellitus and Controls Following Vaccination Against Hepatitis B, Journal of Isfahan Medical School (2007)
25. Occult Hepatitis B Among Iranian Hepatitis C Patients, Journal of Research in Medical Sciences (2009)
26. Analysis of the Related Factors in Hepatitis C Virus Infection Among Hemophilic Patients in Isfahan, Iran, Hepatitis Monthly (2007)
27. Seroprevalence of Hbv, Hcv and Hiv Infection Among Intravenous Drug Users in Shahr-E-Kord, Islamic Republic of Iran, Eastern Mediterranean Health Journal (2008)
28. Probing Rate of Ymdd Motif Mutant in Lamivudine Treatment of Iranian Patients With Chronic Hepatitis B Virus Infection, Asian Journal of Transfusion Science (2011)
29. Hepatitis C Virus Infection in Patients With Hemophilia in Isfahan, Iran, International Journal of Preventive Medicine (2012)
30. Hepatitis C Among Intravenous Drug Users in Isfahan, Iran: A Study of Seroprevalence and Risk Factors, International Journal of Preventive Medicine (2012)
31. The Association of Non-O Blood Group and Severity of Liver Fibrosis in Patients With Chronic Hepatitis C Infection, Journal of Research in Medical Sciences (2012)
32. Prevalence of Hepatitis C Virus, Hepatitis B Virus, Human Immunodeficiency Virus and Related Risk Factors Among Hemophilia and Thalassemia Patients in Iran, Iranian Journal of Clinical Infectious Diseases (2011)
33. Correlation Between Il-28 Polymorphism and Spontaneous Clearance in Hcv Patients: Systematic Review and Meta-Analysis, Archives of Virology (2021)
34. Comparison of the Prevalence and Risk Factors of Hepatitis a in 10 to 18-Year-Old Adolescents of Sixteen Iranian Provinces: The Caspian-Iii Study, Hepatitis Monthly (2016)
35. Global, Regional, and National Burden of Hepatitis B, 1990–2019: A Systematic Analysis for the Global Burden of Disease Study 2019, The Lancet Gastroenterology and Hepatology (2022)
36. Seroprevalence of Hepatitis a in Iranian Adolescents: Is It Time to Introduce a Vaccine?, Epidemiology and Infection (2016)
37. Prevalence and Risk Factors for Hepatitis B and Hepatitis C Exposure in Iranian Prisoners: A National Study in 2016, Hepatitis Monthly (2019)
38. Hepatitis B Virus Surface Antigen Variants Clustered Within Immune Epitopes in Chronic Hepatitis B Carriers From Hormozgan Province, South of Iran, Iranian Journal of Basic Medical Sciences (2010)
39. Positive Hepatitis C Virus Antibody in Cases With History of Intravenous Drug Abuse Via Community Announcement: A Useful Experience, Journal of Isfahan Medical School (2011)
40. Detection of the Predominant Hepatitis C Virus Genotypes Using Linear Probe Assay for 5'Nc Region in Iran, Biotechnology (2012)
41. Prevalence of Hbv and Hcv Infections and Associated Risk Factors in Addict Prisoners, Iranian Journal of Public Health (2006)
42. Hepatitis B and C Among Patients Infected With Human Immunodeficiency Virus in Isfahan, Iran: Seroprevalence and Associated Factors, Hepatitis Monthly (2010)
43. Seroepidemiology of Hepatitis a Virus Infections in Over 6-Years Population in Isfahan–Iran: A Community-Based Study, Journal of Isfahan Medical School (2007)
44. Prevalence and Risk Factors of Hepatitis B Infection in Injection Drug Users, Tehran (2001-2002), Hepatitis Monthly (2008)
45. Hepatitis B in Patients With End-Stage Renal Disease Undergoing Maintenance Hemodialysis, Journal of Isfahan Medical School (2016)
46. Seroprevalence of Hepatitis a Virus in Patients With Chronic Hepatitis B or C in Isfahan Province, Iran, Journal of Isfahan Medical School (2012)
47. Seroprevalence of Hepatitis B Virus and Human Immunodeficiency Virus Among Young Prisoners, Journal of Research in Medical Sciences (2013)
48. Hepatitis C Screening in Intravenuos Drug Users in Golpayegan, Isfahan Through Community Announcement: Pilot Study, Journal of Isfahan Medical School (2011)
49. Identification of Hepatitis B Virus Surface Antigen (Hbsag) Genotypes and Variations in Chronic Carriers From Isfahan Province, Iran, Iranian Journal of Public Health (2012)
50. Histopathologic Criteria to Differentiate Autoimmune Hepatitis From Chronic Viral Hepatitis (B, C) in Liver Biopsy, Polish Annals of Medicine (2017)